Timestamps : 00:00:00 Cold Open: The Visceral Fat Finding 00:00:49 The Scale Problem What Body Weight Actually Measures 00:03:50 What Is Visceral Fat and Why It's Not Just "Belly Fat" 00:05:04 Three Competing Theories: How Visceral Fat Actually Causes Disease 00:08:35 Adipokines: PAI-1, Angiotensinogen, and What Happens When Adiponectin Drops 00:09:52 How to Measure: Three Sites That Don't Give the Same Number 00:14:30 Clinical Thresholds, Ethnic Adjustments, and the Waist-to-Height Ratio 00:15:45 The Weight-to-Waist Ratio: Tracking the Quality of Your Fat Loss 00:19:20 Sleep, Cortisol, and Why the Hormonal Environment Has to Support the Work 00:21:24 Why Exercise Reduces Visceral Fat 6 More Than Diet Alone 00:22:02 Mechanism 1 Beta-3 Adrenergic Receptors and Preferential Visceral Fat Mobilization 00:24:10 Mechanism 2 Myokines: The Fat-Burning Signal Only Contracting Muscle Can Send 00:26:21 GLP-1 Agonists and Body Composition: What the Clinical Trials Actually Show 00:28:05 DXA's Blind Spot: Myosteatosis, Glycogen, and Why Lean Mass Numbers Are Inflated 00:30:10 SEMALEAN, the BELIEVE Trial, and the 1-in-10 Reality of Long-Term Lifestyle Programs 00:33:15 Testosterone, Visceral Fat, and the Aromatase Feed-Forward Loop 00:36:05 Three Testosterone Ranges: Deficient, Eugonadal, and Supraphysiological 00:38:05 The Bhasin 4-Group Study and Why AAS Are a Class, Not a Synonym for TRT 00:39:33 Tesamorelin: The GHRH Analogue That Selectively Targets Visceral Fat 00:40:53 Practical Framework: What to Measure, When, and What to Do 00:43:20 Key Takeaways Next Steps For evidence-based resistance training programs: barbellmedicine.com/training-programs For individualized training consultation: barbellmedicine.com/coaching Explore our full library of articles on health and performance: barbellmedicine.com/resources To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: To consult with Drs
When it comes to protecting your cells from oxidative stress, few compounds get as much attention as glutathione and N-acetylcysteine (NAC)
Davies, Lipid-lowering effect of berberine in human subjects and rats, Phytomedicine, Volume 19, Issue 10, 2012, Pages 861-867, ISSN 0944-7113,
Patients beginning treatment with semaglutide can expect a gradual weight loss trajectory
5.3 Antidepressant and anxiolytic effects Elevated levels of systemic inflammation, neuroinflammation, and hyperactivity of the hypothalamicpituitaryadrenal (HPA) axis have been identified as key factors contributing to the pathogenesis of neuropsychiatric disorders, including depression and anxiety (7074)
Store in a cool, dark, and dry place below 25C and protect from sunlight
